These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17119122)

  • 1. TACI regulates IgA production by APRIL in collaboration with HSPG.
    Sakurai D; Hase H; Kanno Y; Kojima H; Okumura K; Kobata T
    Blood; 2007 Apr; 109(7):2961-7. PubMed ID: 17119122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.
    Kanswal S; Katsenelson N; Selvapandiyan A; Bram RJ; Akkoyunlu M
    J Immunol; 2008 Jul; 181(2):976-90. PubMed ID: 18606649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues.
    Eslami M; Schuepbach-Mallepell S; Diana D; Willen L; Kowalczyk-Quintas C; Desponds C; Peter B; Vigolo M; Renevey F; Donzé O; Luther SA; Yalkinoglu Ö; Alouche N; Schneider P
    Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2404309121. PubMed ID: 38990948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
    Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
    J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the BAFF/APRIL system in the T cell-independent specific response to blood stage Plasmodium falciparum hemozoin.
    Dechkajorn W; Benjathummarak S; Kumsiri R; Maneerat Y
    Cytokine; 2018 Nov; 111():445-453. PubMed ID: 29884307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
    Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
    Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
    J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APRIL is overexpressed in cancer: link with tumor progression.
    Moreaux J; Veyrune JL; De Vos J; Klein B
    BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
    Takahara M; Nagato T; Nozaki Y; Kumai T; Katada A; Hayashi T; Harabuchi Y
    Cell Immunol; 2019 Jul; 341():103925. PubMed ID: 31088610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking.
    Kimberley FC; van Bostelen L; Cameron K; Hardenberg G; Marquart JA; Hahne M; Medema JP
    FASEB J; 2009 May; 23(5):1584-95. PubMed ID: 19141538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APRIL mediates peritoneal B-1 cell homeostasis.
    Sindhava VJ; Scholz JL; Stohl W; Cancro MP
    Immunol Lett; 2014 Aug; 160(2):120-7. PubMed ID: 24512739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.
    Banday VS; Thyagarajan R; Sundström M; Lejon K
    Immunology; 2016 Nov; 149(3):297-305. PubMed ID: 27444337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
    Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A
    Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
    Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
    J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired B cell receptor signaling is responsible for reduced TACI expression and function in X-linked immunodeficient mice.
    Uslu K; Coleman AS; Allman WR; Katsenelson N; Bram RJ; Alugupalli KR; Akkoyunlu M
    J Immunol; 2014 Apr; 192(8):3582-95. PubMed ID: 24646744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.
    Rickert RC; Jellusova J; Miletic AV
    Immunol Rev; 2011 Nov; 244(1):115-33. PubMed ID: 22017435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.
    Bossen C; Cachero TG; Tardivel A; Ingold K; Willen L; Dobles M; Scott ML; Maquelin A; Belnoue E; Siegrist CA; Chevrier S; Acha-Orbea H; Leung H; Mackay F; Tschopp J; Schneider P
    Blood; 2008 Feb; 111(3):1004-12. PubMed ID: 17942754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas.
    Guadagnoli M; Kimberley FC; Phan U; Cameron K; Vink PM; Rodermond H; Eldering E; Kater AP; van Eenennaam H; Medema JP
    Blood; 2011 Jun; 117(25):6856-65. PubMed ID: 21543761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane activator and calcium modulator and cyclophilin ligand interactor enhances CD40-driven plasma cell differentiation.
    Castigli E; Wilson SA; Elkhal A; Ozcan E; Garibyan L; Geha RS
    J Allergy Clin Immunol; 2007 Oct; 120(4):885-91. PubMed ID: 17689597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.